Develops a smart modular attachment for insulin injection pens with mobile and cloud software that logs injection times and doses and flags dosing errors, intending to earn from the device and from manufacturers integrating it into their own products. A newly acquired majority-held subsidiary adds volatile organic compound biomarker diagnostics.
